scholarly journals Ocular Manifestations of Hospitalized COVID-19 Patients in a Tertiary Care Academic Medical Center in the United States: A Cross-Sectional Study

2021 ◽  
Vol Volume 15 ◽  
pp. 1551-1556
Author(s):  
Yilin Feng ◽  
Jemin Park ◽  
Yunshu Zhou ◽  
Stephen T Armenti ◽  
David C Musch ◽  
...  
2019 ◽  
Vol 6 (10) ◽  
Author(s):  
Jonathan C Cho ◽  
Matthew P Crotty ◽  
Wesley D Kufel ◽  
Elias B Chahine ◽  
Amelia K Sofjan ◽  
...  

Abstract Background Pharmacists with residency training in infectious diseases (ID) optimize antimicrobial therapy outcomes in patients and support antimicrobial stewardship (AS) programs. Although most ID residencies are accredited and assessed by certain standards, the degree to which these programs are similar is not known. Methods A 19-item, cross-sectional, multicentered, electronic survey was distributed via e-mail to pharmacy residency program directors (RPDs) of all 101 second-year postgraduate (PGY-2) ID residency programs in the United States. Results Survey responses were collected from 71 RPDs (70.3%); 64.8% were associated with an academic medical center and 97.2% focused primarily in adult ID. Rotations in the microbiology laboratory, adult AS, and adult ID consult were required in 98.6% of residency programs. Only 28.2% of responding programs required pediatric AS and pediatric ID consult rotations. Programs at academic medical centers were more likely to offer immunocompromised host ID consult (P = .003), pediatric ID consult (P = .006), and hospital epidemiology (P = .047) rotations but less frequently offered outpatient AS (P = .003), viral hepatitis clinics (P = .001), and travel medicine clinics (P = .007) rotations compared to programs at nonacademic medical centers. Residents were frequently involved in AS committees (97.2%), pharmacokinetic dosing of antimicrobials (83.1%), precepting pharmacy trainees (80.3%), and performing research projects (91.5%). Conclusions The PGY-2 ID pharmacy residency programs demonstrated consistency in required adult ID consult, antimicrobial management activities, committee service, and teaching and research opportunities. Pediatric experiences were less common. The PGY-2 ID residency programs prepare pharmacists to become antimicrobial stewards for adult patients.


Vaccine ◽  
2020 ◽  
Vol 38 (7) ◽  
pp. 1597-1600
Author(s):  
Alicia M. Ritscher ◽  
Megan LeClair-Netzel ◽  
Nicholas J. Friedlander ◽  
Danielle N. Howard Stewart ◽  
Mallory Wagner ◽  
...  

2015 ◽  
Vol 40 (1) ◽  
pp. 38-45 ◽  
Author(s):  
Farid Talih ◽  
Razmig Warakian ◽  
Jean Ajaltouni ◽  
Al Amira Safa Shehab ◽  
Hani Tamim

2020 ◽  
Vol 41 (5) ◽  
pp. 505-509 ◽  
Author(s):  
James H. England ◽  
Daniel W. Byrne ◽  
Bryan D. Harris ◽  
Thomas R. Talbot

AbstractObjective:To identify risk factors of patients placed in airborne infection isolation (AII) for possible pulmonary tuberculosis (TB) to better predict TB diagnosis and allow more judicious use of AII.Methods:Case-control, retrospective study at a single tertiary-care academic medical center. The study included all adult patients admitted from October 1, 2014, through October 31, 2017, who were placed in AII for possible pulmonary TB. Cases were defined as those ultimately diagnosed with pulmonary TB. Controls were defined as those not diagnosed with pulmonary TB. Those with TB diagnosed prior to admission were excluded. In total, 662 admissions (558 patients) were included.Results:Overall, 15 cases of pulmonary TB were identified (2.7%); of these, 2 were people living with human immunodeficiency virus (HIV; PLWH). Statistical analysis was limited by low case number. Those diagnosed with pulmonary TB were more likely to have been born outside the United States (53% vs 13%; P < .001) and to have had prior positive TB testing, regardless of prior treatment (50% vs 19%; P = .015). A multivariate analysis using non–US birth and prior positive TB testing predicted an 18.2% probability of pulmonary TB diagnosis when present, compared with 1.0% if both factors were not present.Conclusions:The low number of pulmonary TB cases indicated AII overuse, especially in PLWH, and more judicious use of AII is warranted. High-risk groups, including those born outside the United States and those with prior positive TB testing, should be considered for AII in the appropriate clinical setting.


2018 ◽  
Vol 113 (Supplement) ◽  
pp. S487
Author(s):  
Muhammad Bashir ◽  
Sadat Iqbal ◽  
Ghassan Mubarak ◽  
Michelle Likhtshteyn ◽  
Elliot Bigajer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document